Take Solutions has fixed Tuesday, September 22, 2026 as the cut-off date for determining shareholder eligibility for remote e-voting ahead of its 25th Annual General Meeting.

The company announced the schedule pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The AGM is scheduled to be held on Tuesday, September 29, 2026 at 12:00 pm through Video Conferencing or Other Audio-Visual Means.

E-voting Schedule and Eligibility

Members whose names are recorded in the Register of Members or the Register of Beneficial Owners maintained by the depositories as on the cut-off date will be entitled to vote. The remote e-voting facility will be accessible from Saturday, September 26, 2026 at 9:00 am to Monday, September 28, 2026 at 5:00 pm.

The intimation was issued by Sunil Patra, Managing Director of Take Limited, formerly known as Take Solutions Limited.

TAKE Limited reported a consolidated net profit of ₹108.5 million for FY26, a sharp turnaround from a profit of ₹37.5 million in the prior year that was heavily influenced by one-off gains. The company's revenue from operations stood at ₹541.9 million, emerging from nil in FY25 as its new AI-driven healthcare platforms began generating commercial traction.

The Chennai-based firm, formerly known as TAKE Solutions Limited, submitted its annual report for the financial year ended March 31, 2026, to stock exchanges on September 7, 2026. The results reflect the early stages of a strategic pivot toward digital health and longevity services.

Financial Performance

On a consolidated basis, total income reached ₹608.7 million, up nearly 500% year-on-year. Profit from continuing operations was ₹42.6 million, compared to ₹7.4 million in FY25. The standalone entity also returned to profitability, posting a net profit of ₹27.2 million against a net loss of ₹697.4 million in the previous year.

What the Numbers Show

The consolidated profit figure includes ₹65.9 million from discontinued operations, which accounts for roughly 61% of the total net profit. This indicates that while the core business is stabilizing, the bottom line remains significantly supported by non-recurring items related to past business units. Furthermore, the standalone entity recorded zero revenue from operations, suggesting that all operational income is currently generated through subsidiaries rather than the holding company itself.

Strategic Initiatives

Management highlighted several key developments during the year:

• Launch of Take.Health, an AI-driven consumer health platform.
• Development of a Unified AI Platform for enterprise healthcare infrastructure.
• Entry into the longevity and anti-ageing market with science-backed nutraceuticals.
• Establishment of an Innovation Fund with an initial corpus of ₹50 million to invest in deep-tech health startups.

Audit Qualifications

Statutory auditors M/s. A. Raghavendra Rao & Associates issued a qualified opinion on both standalone and consolidated financial statements. The qualification relates to income tax assets totaling ₹87.6 million (standalone) and ₹129.2 million (consolidated), which are pending adjudication in various forums. The auditors noted they could not confirm the ultimate realizable value of these assets.

Corporate Governance

The Board appointed Mr. Sunil Patra as Managing Director and CFO in May 2026 to fill casual vacancies. The company faced regulatory fines for delays in appointing a Company Secretary and filling board vacancies earlier in the year. The Twenty-Fifth Annual General Meeting is scheduled for September 29, 2026.